The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of nab-paclitaxel (nab-P) plus gemcitabine (G) vs gemcitabine alone on Karnofsky performance status (KPS) in metastatic pancreatic cancer.
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene
Research Funding - Celgene
 
Yin Wan
Employment - Pharmerit
Research Funding - Celgene
 
Scott Whiting
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Louis Kayitalire
Employment - Celgene
Stock and Other Ownership Interests - BioAlliance Pharma; Celgene
Honoraria - BioAlliance Pharma; Celgene
Travel, Accommodations, Expenses - Celgene
 
Marc Botteman
Employment - Pharmerit
Leadership - Pharmerit
Stock and Other Ownership Interests - Pharmerit
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb; Celgene
 
Xiang Ji
Employment - Pharmerit
Research Funding - Bristol-Myers Squibb